| 标题 |
Phase 3 SOPHIA Study of Margetuximab vs Trastuzumab in Patients With HER2+ Metastatic Breast Cancer After Prior Anti-HER2 Therapies: Final Overall Survival Analysis
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | Rugo HS, et al. Phase 3 SOPHIA Study of Margetuximab vs Trastuzumab in Patients With HER2+ Metastatic Breast Cancer After Prior Anti-HER2 Therapies: Final Overall Survival Analysis. Cancer Res. 2024;84(9 Suppl):CT258. |
| 求助人 | |
| 下载 |